Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Market and Distribute a Tobacco Product

Premarket Tobacco Product Applications

                        
                Preparing and Submitting a Premarket Tobacco Product Application
          FDA Tobacco Product Application Tips - Premarket Tobacco Product Applications
          Premarket Tobacco Product Marketing Granted Orders Home
          Tobacco Products
          Products, Guidance & Regulations
          Market and Distribute a Tobacco Product
          Premarket Tobacco Product ApplicationsMarket and Distribute a Tobacco Product Premarket Tobacco Product Applications
  	
        Share
    Post
    Linkedin

    Email
    Print**On this page:**

What Are Premarket Tobacco Product Applications (PMTAs)?
	What Is the Final PMTA Rule?
	Preparing and Submitting a PMTA
	PMTA Review Process
	PMTA DecisionsWhat Are Premarket Tobacco Product Applications (PMTAs)?

A premarket tobacco product application (PMTA) can be submitted by any person for any new tobacco product seeking an FDA marketing order, under section 910(b) of the Federal Food, Drug, and Cosmetic Act (FD&C Act). A PMTA must provide scientific data that demonstrates a product is appropriate for the protection of public health. In order to reach such a decision and to authorize marketing, FDA considers (per section 910(c)(4)), among other things:

Risks and benefits to the population as a whole, including people who would use the proposed new tobacco product as well as nonusers
	Whether people who currently use any tobacco product would be more or less likely to stop using such products if the proposed new tobacco product were available
	Whether people who currently do not use any tobacco products would be more or less likely to begin using tobacco products if the new product were available
	The methods, facilities, and controls used to manufacture, process, and pack the new tobacco productWhat Is the Final PMTA Rule?

In 2021, FDA finalized the PMTA rule that describes the required content, format, and review of PMTAs. For FDA to complete a substantive review of a PMTA, the application must include the information described in the final rule. The rule also requires manufacturers to maintain records establishing that their tobacco products are legally marketed.

The final PMTA rule includes information on how to amend or withdraw an application, how FDA communicates with the applicant, and FDA's disclosure procedures.

Preparing and Submitting a PMTA

FDA has information and resources to help applicants prepare and submit PMTAs that meet the requirements outlined in the final PMTA rule. For example, applicants can learn more about:

What needs to be included in a PMTA
	How to submit a PMTA
	How to group PMTA submissions
	When to submit supplemental PMTAs, resubmissions, and amendmentsAdditionally, you canfind tips for correctly completing PMTA forms.

PMTA Review Process

PMTA Review Process work flow
**Presubmission Meetings**: A voluntary formal meeting between the applicant and FDA to discuss a planned PMTA submission for a tobacco product. For more information, see Meetings with Industry and Investigators.

	Output
		Meeting granted letter or
			Meeting denial letter
			Meeting minutes letter (if meeting is granted and held)
	**Acceptance Review**: An initial review that ensures the product falls under Center for Tobacco Products jurisdiction and confirms that the statutory and regulatory requirements of an application are met based upon Section 910 of the FD&C Act and the criteria set forth in § 1114.27(a)(1).
	Output
		Acceptance letter or
			Refuse to accept (RTA) letter, as outlined in: Refuse To Accept Procedures for Premarket Tobacco Product Submissions
	**Filing Review:** A threshold determination of whether the application contains sufficient information to permit a substantive review. FDA may refuse to file a PMTA if any of the criteria in § 1114.27(b)(1) apply.
	Output
		Filing letter or
			Refuse to file (RTF) letter, as outlined in the PMTA final rule
	**Application Review**: FDA evaluation of the scientific information and data in an application, as well as recommendations from the Tobacco Product Scientific Advisory Committee (TPSAC), if the application was referred.
	Output
		**Deficiency letter**: Additional information is needed to complete scientific review. The letter will specify the number of days an applicant has to respond.
			**Environmental information request letter**: FDA made a scientific decision to issue a marketing granted order; however, the applicant is required to provide information for environmental considerations before a marketing granted order can be issued.
	**Action**:
	Output includes
		Marketing granted order letter or
			Marketing denial order letter
	**Postmarket Requirements**: Requires applicants to establish and maintain records and make reports that FDA requires as necessary to determine or facilitate a determination of whether there may be grounds to withdraw or temporarily suspend a marketing granted order. Postmarket reporting requirements for all products that receive a marketing granted order are set forth in § 1114.41 and FDA may require additional reporting under the terms of a marketing granted order.In 2021, CTP held “A Conversation With the Center for Tobacco Products Office of Science” to help industry understand the FDA review process for marketing applications related to deemed tobacco products.

PMTA Decisions

Marketing Granted Orders for PMTA
	Marketing Denial Orders for PMTA

                                                                                  Content current as of:
      08/31/2023
                  
                   
Regulated Product(s)
		 TobaccoPremarket Tobacco Product Applications                
                          

                        Preparing and Submitting a Premarket Tobacco Product Application
          FDA Tobacco Product Application Tips - Premarket Tobacco Product Applications
          Premarket Tobacco Product Marketing Granted Orders
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop